Irccs Crob
Potenza 85028
0 studies enrolling now ยท 1 studies all time
What they study most
Lymphoma, Mantle-Cell
Studies at this site
Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL)
โ Running, not enrolling